Advancing intestinal ultrasound to improve lives of IBD patients
We believe IBD care needs significant improvement. Despite advances in medicine, the journey of those living with IBD remains unpredictable. Intestinal ultrasound is the non-invasive tool transforming how we manage it.
Supported by leading institutions and organizations
Leadership
Noa Krugliak Cleveland, MD
Co-Founder, Chief Executive Officer, President
University of Chicago
Dr. Noa Krugliak Cleveland is the President and Chief Executive Officer of iUSCAN and the Director of the IUS Program at the University of Chicago Medicine, where she trains North American clinicians in IUS. A global leader in IUS education and research, her work advances the use of IUS in IBD care, improving outcomes across North America and beyond.
Michael Dolinger, MD, MBA
Co-Founder, Chief Operating Officer, Treasurer
NYU Grossman School of Medicine
Dr. Michael Dolinger is the Treasurer and Chief Operating Officer of iUSCAN and the Director of Pediatric Inflammatory Bowel Disease at NYU Langone Health. As an expert in IUS, he leads global education initiatives and his research highlights its role in enhancing IBD clinical trials and treatment prognostication, especially for children and pregnant women.
Michael Winter, MD
Chief Programming Officer, Secretary
Dartmouth Hitchcock Medical Center
Dr. Michael Winter is the Secretary and Chief Programming Officer of iUSCAN and the Gastroenterology Fellowship Director Walter and Carole Young Center for Digestive Health at the Dartmouth Hitchcock Medical Center. His clinical, education, and research interests focus on enhancing IUS training and education and understanding impacts of IUS on patient engagement in the management of IBD.
Cathy Lu, MD
Chief Scientific Officer, Director
University of Calgary
Dr. Cathy Lu isa Director and the Chief Scientific Officer of iUSCAN and a Clinical Assistant Professor of Medicine at the University of Calgary. Her research focuses on the use of IUS as a precision medicine tool in the diagnosis and treatment of fibrostenotic Crohn’s disease.
David T. Rubin, MD
Chief Strategy Officer, Director
University of Chicago
Dr. David T. Rubin is a Director and the Chief Strategy Officer of iUSCAN and the Chief of the Section of Gastroenterology, Hepatology, and Nutrition and Director of the Inflammatory Bowel Disease Center at the University of Chicago Medicine. His research is focused on disease modification in IBD including clinical trial designs, novel measures of inflammation, prevention of adverse outcomes, and quality of life in IBD.
Corey A. Siegel, MD, MS
Strategic Advisor, Director
Dartmouth Hitchcock Medical Center
Dr. Corey A. Siegel is a Director and Strategic Advisor for iUSCAN and the Director of the Walter and Carole Young Center for Digestive Health at the Dartmouth Hitchcock Medical Center. His research is focused on understanding risk/benefit tradeoffs in IBD, developing models to predict outcomes in Crohn’s disease, creating tools to facilitate shared decision making, expanding telemedicine services to patients with IBD living in rural locations, and improving the quality of care delivered to patients with IBD.
Committee Chairs
Our committees bring together leading experts to drive education, research, and clinical standards in intestinal ultrasound.
Amelia Kellar, MD
Research Committee Chair
University of Chicago
Rishika Chugh, MD
Education Committee Chair
University of California San Francisco
Phillip Gu, MD
Clinical Implementation Committee Chair
Cedars-Sinai
David Ziring, MD
Advocacy Committee Chair
Cedars-Sinai
Jennifer de Bruyn, MD
Pediatrics Committee Chair
University of Calgary
Joelle St-Pierre, MD
Research Committee Vice Chair
University of Calgary
Jeff Jacobs, MD
Education Committee Vice Chair
Northwestern
Sanket Patel, DO
Clinical Implementation Committee Vice Chair
Virtua Health
Jennifer Semenerio, MD
Advocacy Committee Vice Chair
Advent Health
Matthew Smyth, MD
Pediatrics Committee Vice Chair
University of British Columbia
Our Story
2019
The first gastroenterologists in the United States undergo intestinal ultrasound (IUS) training via the International Bowel Ultrasound Group (IBUS) curriculum.
2022
The first IBUS module 1 hands-on training in the United States occurs at the Icahn School of Medicine at Mount Sinai, introducing IUS to 36 new centers in the United States and Canada, increasing interest and demand among both gastroenterologists and patients.
2022
Dr. David Rubin and the University of Chicago receive a 3-year grant from the Leona M. and Harry B. Helmsley Charitable Trust to expand IUS in North America, forming a research alliance with IBUS, Mount Sinai, and the University of Calgary. iUSCAN was founded to meet growing demand, focusing on IUS education, training, research and advocacy in IBD care.
2024
As the initial grant funding from the Helmsley Charitable Trust comes to an end, iUSCAN is established as an official non-profit organization, allowing the organization to grow independently to continue to meet the IUS needs of North America.
2026
The next chapter — continuing to expand intestinal ultrasound education, research, and adoption across North America.
For organizations
Partner with iUSCAN
Be part of a growing network dedicated to the advancement of intestinal ultrasound. Work with us to develop educational programs, research initiatives, and clinical practices that set new standards in IBD.
- → Access to a global clinical research network
- → Gain visibility at leading international conferences
- → Collaboration with top IBD specialists
- → Funding / grants / exposure
Contact Us
Have a question, want to get involved, or interested in partnering with iUSCAN? We'd love to hear from you.